---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-191340"
form_type: "8-K"
ticker: "FULC"
cik: "0001680581"
company_name: "Fulcrum Therapeutics, Inc."
filed_at: "2022-07-11T23:59:59+00:00"
generated_at: "2026-06-24T17:33:21.038815+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Chief Medical Officer Chris Morabito resigns effective July 13, 2022

## Summary
- Chris Morabito, M.D., stepped down as Chief Medical Officer of Fulcrum Therapeutics.
- Resignation effective July 13, 2022; he left to pursue another opportunity.
- No replacement announced; departure not due to any disagreement with company.
- Morabito's resignation follows no known operational or financial disputes.
- Fulcrum did not provide details on interim CMO or search timeline.

## SEC filing metadata
- accession: 0001193125-22-191340
- form_type: 8-K
- ticker: FULC
- cik: 0001680581
- company_name: Fulcrum Therapeutics, Inc.
- filed_at: 2022-07-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1680581/000119312522191340/0001193125-22-191340-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1680581/000119312522191340/d338706d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-191340
- JSON: https://secwatch.observer/filing/0001193125-22-191340.json
- Plain text: https://secwatch.observer/filing/0001193125-22-191340.txt

## Key facts
- Executive change
  Chris Morabito, M.D. resigned as Chief Medical Officer at Fulcrum Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Medical Officer
  source text: On July 8, 2022, Chris Morabito, M.D., Chief Medical Officer of Fulcrum Therapeutics, Inc., or Fulcrum, notified Fulcrum of his resignation from this position and from his employment with Fulcrum, to be effective on July 13, 2022, in order to pursue a new opportunity.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1680581/000119312522191340/0001193125-22-191340-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.